Literature DB >> 33628512

Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis.

Mohamed Abd Ellatif Afifi1, Ahmed Mohamed Hussein1, Mahmoud Rizk1.   

Abstract

BACKGROUND: Patients with liver cirrhosis experience a large variety of metabolic disorders associated with more hepatic decompensation. Hepatic encephalopathy (HE) is a significant complication in liver cirrhosis patients, presenting a wide spectrum of neuropsychological symptoms. A deficiency of 25-hydroxy vitamin D (25-OHD) in the general population is associated with a loss of cognitive function, dementia, and Alzheimer's disease. Aim of the Study. Our study aims to check the relationship between low serum 25-OHD and HE in patients with HCV-related liver cirrhosis and assess its link with patient mortality. Patients and Methods. This study was observationally carried out on 100 patients with HCV-related liver cirrhosis. The patients were divided into 2 groups: Group A-included 50 HCV-related cirrhotic patients with HE, and Group B-included 50 HCV-related cirrhotic patients without HE. Assessment of disease severity using the end-stage liver disease (MELD) model and Child Turcotte Pugh (CTP) scores were done, and 25-OHD levels were measured. Comparison of vitamin D levels in different etiologies and different CTP categories was made using one-way ANOVA. Pearson's correlation between the level of vitamin D and other biomarkers was applied.
RESULTS: There was a statistically significant Vitamin D level difference between the two groups. A lower level of vitamin D was observed in the HE group where the severe deficiency was 16%, while it was 6% in the other group and the moderate deficiency was 24% in HE group as compared to 10% in the other group. The insufficient vitamin D level represented 46% of the non-HE group while none of the HE group falls in this category. Vitamin D level was statistically higher in Grade 1 HE than in Grade 2 which is higher than in Grades 3 to 4. Vitamin D level was also significantly higher in those who improved from HE as compared to those who died.
CONCLUSION: The lower levels of 25-OHD were associated with the higher incidence of HE in cirrhotic HCV patients. The worsening vitamin D deficiency was associated with increased severity of the liver disease, so vitamin D may be considered a prognostic factor for the severity of liver cirrhosis and high mortality rate in HE patients.
Copyright © 2021 Mohamed Abd Ellatif Afifi et al.

Entities:  

Year:  2021        PMID: 33628512      PMCID: PMC7896845          DOI: 10.1155/2021/6669527

Source DB:  PubMed          Journal:  Int J Hepatol


  58 in total

Review 1.  New assessment of hepatic encephalopathy.

Authors:  Juan Córdoba
Journal:  J Hepatol       Date:  2010-12-05       Impact factor: 25.083

2.  Association of markers of bacterial translocation with immune activation in decompensated cirrhosis.

Authors:  Christian Mortensen; Jørgen Skov Jensen; Lise Hobolth; Sanne Dam-Larsen; Bjørn S Madsen; Ove Andersen; Søren Møller; Flemming Bendtsen
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-12       Impact factor: 2.566

3.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

Review 4.  Where is the vitamin D receptor?

Authors:  Yongji Wang; Jinge Zhu; Hector F DeLuca
Journal:  Arch Biochem Biophys       Date:  2012-04-06       Impact factor: 4.013

Review 5.  Vitamin D and the brain.

Authors:  Lauren R Harms; Thomas H J Burne; Darryl W Eyles; John J McGrath
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-08       Impact factor: 4.690

6.  Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.

Authors:  Csilla Putz-Bankuti; Stefan Pilz; Tatjana Stojakovic; Hubert Scharnagl; Thomas R Pieber; Michael Trauner; Barbara Obermayer-Pietsch; Rudolf E Stauber
Journal:  Liver Int       Date:  2012-01-04       Impact factor: 5.828

7.  Prevalence of vitamin D deficiency in chronic liver disease.

Authors:  J Arteh; S Narra; S Nair
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

8.  [Vitamin D deficiency in chronic liver disease, clinical-epidemiological analysis and report after vitamin d supplementation].

Authors:  Nereida Fernández Fernández; Pedro Linares Torres; Diana Joáo Matias; Francisco Jorquera Plaza; Jose Luis Olcoz Goñi
Journal:  Gastroenterol Hepatol       Date:  2015-12-01       Impact factor: 2.102

Review 9.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13

10.  Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA).

Authors:  J H Moon; S Lim; J W Han; K M Kim; S H Choi; K W Kim; H C Jang
Journal:  Clin Endocrinol (Oxf)       Date:  2015-03-04       Impact factor: 3.478

View more
  1 in total

Review 1.  Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease.

Authors:  Federico Ravaioli; Alessandra Pivetti; Lorenza Di Marco; Christou Chrysanthi; Gabriella Frassanito; Martina Pambianco; Chiara Sicuro; Noemi Gualandi; Tomas Guasconi; Maddalena Pecchini; Antonio Colecchia
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.